Barry J. Simon insider trades: ImmunityBio (IBRX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Barry reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | IBRX | ↓ Sell | 25,000 | $10.75 | $269K | Direct | Oct 6, 2026 (1d) |
| Jun 24, 2026 | IBRX | ↓ Sell | 25,000 | $7.88 | $197K | Direct | Jun 26, 2026 (2d) |
| Feb 24, 2026 | IBRX | ↓ Sell | 75,000 | $12.01 | $901K | Direct | Feb 26, 2026 (2d) |
| Feb 23, 2026 | IBRX | ↓ Sell | 175,000 | $10.19 | $1.8M | Direct | Feb 24, 2026 (1d) |
| Jan 20, 2026 | IBRX | ↓ Sell | 151,967 | $7.20 | $1.1M | Direct | Jan 21, 2026 (1d) |
| May 25, 2021 | IBRX | ↓ Sell | 125,000 | $16.14 | $2.0M | Direct | May 25, 2021 (0d) |
| Feb 5, 2021 | NK | ↓ Sell | 22,100 | $23.09 | $510K | Direct | Feb 8, 2021 (3d) |
| Feb 2, 2021 | NK | ↓ Sell | 82,070 | $20.65 | $1.7M | Direct | Feb 4, 2021 (2d) |
| Jan 28, 2021 | NK | ↓ Sell | 47,930 | $20.59 | $987K | Direct | Jan 29, 2021 (1d) |
| Dec 22, 2020 | NK | ↓ Sell | 130,000 | $18.05 | $2.3M | Direct | Dec 28, 2020 (6d) |
| Jul 21, 2020 | NK | ↓ Sell | 130,000 | $15.53 | $2.0M | Direct | Jul 22, 2020 (1d) |
| Jul 8, 2020 | NK | ↓ Sell | 39,950 | $13.14 | $525K | Direct | Jul 10, 2020 (2d) |
| Jun 30, 2020 | NK | ↓ Sell | 9 | $13.00 | $117 | Direct | Jul 2, 2020 (2d) |
| Jun 23, 2020 | NK | ↓ Sell | 200,041 | $10.56 | $2.1M | Direct | Jun 23, 2020 (0d) |
| May 27, 2020 | NK | ↓ Sell | 75,000 | $7.56 | $567K | Direct | May 29, 2020 (2d) |
| May 21, 2020 | NK | ↓ Sell | 36,932 | $5.52 | $204K | Direct | May 22, 2020 (1d) |
| May 11, 2020 | NK | ↓ Sell | 28,068 | $5.50 | $155K | Direct | May 13, 2020 (2d) |
| Sep 8, 2016 | NK | ↓ Sell | 30,000 | $7.40 | $222K | Direct | Sep 9, 2016 (1d) |
| Sep 7, 2016 | NK | ↓ Sell | 2,000 | $8.84 | $18K | By mother-in-law | Sep 9, 2016 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IBRX insiders
Open-market trades in the last 12 months
About Barry J. Simon's insider trades
Barry J. Simon is a director at ImmunityBio (IBRX). Since Sep 7, 2016, Barry has reported no open-market purchases and 19 sales worth $17.6M on SEC Form 4. In the last 12 months: 5 sales ($4.2M).
Their filings also include option exercises (17 filings), grants and awards (12 filings), shares withheld for taxes (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IBRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.